• Easy-to-install system with reclining patient chair and Windows cybersecurity package provides low total cost of ownership
Siemens Healthineers has introduced a new version of its c.cam dedicated cardiac nuclear medicine system to the U.S. market. This single-photon emission computed tomography (SPECT) scanner with a reclining patient chair offers nuclear cardiology providers a low total cost of ownership, ease of installation, and a high level of image quality.
The c.cam has a comfortable, reclining patient chair with a 450 lb. weight limit rather than a flat table. This chair improves access to care by allowing the patient to remain seated comfortably during scanning to minimize respiratory motion and cardiac image artifacts. The system’s integrated, bi-directional camera arm permits easier patient positioning, and the small field of view is optimized for cardiac procedures. The scanner’s new Windows software platform contains enhanced cybersecurity features that limit access by non-authorized personnel. With a small 8 ft. x 8 ft. footprint, the c.cam can be installed in just two days with minimal room modeling requirements. Applications training can be completed in only three days. The c.cam also has a standard five-year warranty.
"This new version of the c.cam SPECT scanner, which is being introduced in response to customer demand, is designed to provide an affordable, easy-to-install system that doesn’t sacrifice image quality and enhances the overall patient experience,” said John Khoury, Vice President of Molecular Imaging at Siemens Healthineers North America.
Contact for journalists
Phone: (484) 868-8346; E-mail: email@example.com
For further information on the c.cam, please see
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2019, which ended on September 30, 2019, Siemens Healthineers, which has approximately 52,000 employees worldwide, generated revenue of €14.5 billion and adjusted profit of €2.5 billion.
Further information is available at www.siemens-healthineers.com.